Distribution and Drug Resistance of Main Pathogens Isolated from Blood Culture from 2012 to 2014
10.3969/j.issn.1671-7414.2015.03.030
- VernacularTitle:2012～2014年医院血培养主要病原菌分布及耐药性分析
- Author:
Huali ZHAI
;
Yanli LIU
;
Lili DING
;
Qingni CHENG
;
Aimin ZOU
;
Jianjun SHEN
- Publication Type:Journal Article
- Keywords:
bloodstream infections;
pathogen;
resistance;
rational drug use
- From:
Journal of Modern Laboratory Medicine
2015;(3):104-106,110
- CountryChina
- Language:Chinese
-
Abstract:
Objective To understand the distribution and drug resistance of pathogens isolated from blood culture samples Chang’an Hospital from 2012 to 2014 to provide basis for rational use of antibacterial drugs.Methods The clinical date of distribution,changes and drug resistance of main pathogens in blood culture samples during 2012 and 2014 in chang anhospi-tal were retrospectively analyzed.Results 512 pathogenic bacterial strains were isolated from 4 792 blood culture samples in 2012~2014.Among them,gram-negative bacteria accounted for 62.50% (320/512),Escherichia coli ,Klebsiella pneumoni-ae and Pseudomonas aeruginosa accounted for 25.20% (129/512),14.26% (73/512)and 8.20% (42/512)respectively;Gram-positive bacteria accounted for 29.30% (150/512),Staphylococcus aureus and Coagulase-negative Staphylococcus ac-counted for 11.52% (59/512)and 10.16% (52/512)respectively.The rate of fungi was 7.62% (39/512).Susceptibility re-sults showed that Escherichia coli and Klebsiella pneumoniae had highly sensitive to carbapenems,but had a varying degrees of resistance to other antibacterial drugs.The rate of drug resistant of Gram-positive cocci to Penicillin,Erythromycin and Clindamycin had been a high level,but no strains being resistant to van comycin and linezolid had been detected.Conclusion The pathogens causing bloodstream infection widely distribute,and have highly drug-resistant.It is necessary to under-stand the distribution of pathogens isolated from blood culture as well as the changes of drug resistance in a timely manner so as to guide the reasonable clinical medication.
